NCT07333417 Effects of Rigid Taping in Acromioclavicular Joint Degeneration
| NCT ID | NCT07333417 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Shoulder Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-03-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2026-01-01 with a primary completion date of 2026-03-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine whether rigid taping applied to the acromioclavicular (AC) joint can reduce shoulder pain and improve shoulder function in people with AC joint degeneration. Participants with shoulder pain and a confirmed diagnosis of AC joint degeneration will be randomly assigned to one of two groups: (1) rigid taping plus a standardized exercise program or (2) the same exercise program without taping. The program will last 4 weeks, with weekly supervised visits. Pain, shoulder motion, and shoulder function will be assessed at baseline, after the first session (acute effect), at the end of treatment (Week 4), and at a 3-month follow-up.
Eligibility Criteria
Inclusion Criteria: * A clinical diagnosis of acromioclavicular (AC) joint degeneration confirmed by clinical examination and imaging (X-ray, ultrasound, or MRI). * Shoulder pain duration of at least 4 weeks. * Age between 18 and 65 years * Willingness to refrain from any additional treatments outside the study protocol during the study period (e.g., medication changes, injections, or physiotherapy elsewhere) and to provide written informed consent Exclusion Criteria: * Current or previous diagnosis/history of acromioclavicular (AC) joint separation. * Diagnosis of frozen shoulder (adhesive capsulitis). * History of acute trauma or fracture involving the shoulder girdle (e.g., clavicle fracture, shoulder dislocation). * History of shoulder surgery. * Systemic inflammatory joint disease (e.g., rheumatoid arthritis) or other systemic arthropathies. * Skin conditions preventing taping (e.g., rash, open wound, or known tape allergy). * Neuromuscular disease or neurological disorders affecting shoulder function
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07333417 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07333417 currently recruiting?
Yes, NCT07333417 is actively recruiting participants. Contact the research team at iremduzgun@hacettepe.edu.tr for enrollment information.
Where is the NCT07333417 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07333417 clinical trial?
NCT07333417 is sponsored by Hacettepe University. The trial plans to enroll 28 participants.